Movement Disorders Clinical Practice

Cover image for Vol. 4 Issue 3

Edited By: Kailash Bhatia, MD, DM, FRCP, Eastern Hemisphere Chief Editor and Marcelo Merello, MD, PhD, Western Hemisphere Chief Editor

Online ISSN: 2330-1619



Author Guidelines


QUICK LINKS:

Editorial Office: Emily Hammond, Managing Editor

mdcpedoffice@movementdisorders.org

Phone: (919) 650-1459, ext. 211

MANUSCRIPT PRE-SUBMISSION AND ETHICAL PUBLICATION GUIDELINES

Movement Disorders Clinical Practice complies with recommendations of the International Committee of Medical Journal Editors (http:// www.ICMJE.org), is a member of the Committee on Publication Ethics (COPE), and adheres to its principles ( http://publicationethics.org/)

Authors are required to include a statement at the end of their manuscript affirming that they have read the following Journal’s Ethical Publication Guidelines. Manuscripts that do not conform to these guidelines will not be considered for publication. Discovery of or failure to comply will result in rejection of the manuscript, retraction of the published article, and/or a ban on future submissions by the author(s).

In submitting a manuscript, the submitting/corresponding author must acknowledge that: a) all co-authors have been substantially involved in the study and/or the preparation of the manuscript; b) no undisclosed groups or persons have had a primary role in the study and/or in manuscript preparation (i.e., there are no “ghost-writers”); and c) all co-authors have seen and approved the submitted version of the paper, accept responsibility for its content, and agree to the order of author names. The Editors reserve the right to require authors to submit their original data for comparison with the manuscript’s illustrations, tables, and results.

Funding Sources, Conflicts of Interest and Financial Disclosures


Funding Sources and Conflict of Interest:
all funding sources and potential conflicts of interest from each author that relate to the research covered in the article, regardless of date, must be documented. If none, please state: “No specific funding was received for this work” and/or “The authors declare that there are no conflicts of interest relevant to this work.”

Financial Disclosures for the previous 12 months: each author must report all funding sources not related to the current research in the article. If none, please state: “The authors declare that there are no additional disclosures to report.”

See Manuscript Formatting (9) for more details.

Position on Experimental Investigation of Human and Animal Subjects
For experimental investigation of human or animal subjects, please state in the Methods section that an appropriate institutional review board approved the project in accordance with all applicable national and/or international guidelines/laws. The authors should also provide their allowance number for performing animal experiments when available and should add a statement indicating that the principles outlined in the ARRIVE guidelines and the Basel declaration (http:// www.basel.declaration.org) including the 3R concept have been considered when planning the experiments.

For those investigators who do not have formal ethics review committees, the principles outlined in the “Declaration of Helsinki” should be followed. For investigations in human subjects, state in the Methods section the manner in which informed consent was obtained from the subjects.

Ethical conduct of research should be explicitly disclosed in all type of articles published in MDCP including case reports, case series, phenomenology videos, clinical vignettes and clinicopathological cases.

Patient Confidentiality
Authors are responsible for ensuring anonymity when required in photographs, patient descriptions, and pedigrees in which a possibility of identification exists. When submitting a patient video or photograph in which a patient can be identified, the corresponding author must provide the journal with written confirmation (via the author copyright form, Section H) that permission has been obtained from the patient, patient’s guardian or, in the event of the patient being deceased, next of kin, that stipulates that authorization has been obtained in compliance with any laws regarding patient authorizations relating to the use or disclosure of protected health information of the jurisdiction(s) to which the patient and the physician are subject including, if applicable, the United States Health Insurance Portability and Accountability Act of 1996 (“HIPAA”).

According to HIPAA, the following core elements must be included in the consent form:
1. A specific and meaningful description of the information to be used
2. The name of the Physician and/or Hospital allowed to disclose the information
3. That the video clip and/or photograph will be submitted for publication in a peer-reviewed medical journal
4. That the video clip and/or photograph will eventually be used by the readers of a peer-reviewed medical journal for educational purposes
5. An expiration date that relates to the individual or the purpose of the use or disclosure
6. The individual’s signature and the date the authorization is signed.
In addition, the patient’s consent form should include the following:

  • A statement that the Patient has the right to revoke his or her consent in writing
  • A statement regarding whether the Physician has the ability to condition medical treatment on the Patient’s giving such consent
  • A statement that information, once disclosed, may be subject to further disclosure by the recipient journal, in which case confidentiality would no longer be assured. The consenting party must understand, additionally, that in some cases the video might be re-presented elsewhere because the journal has policies that allow permissions and/or use copyrighted materials with other educational organizations. The consenting party must understand that in such a case the signed author’s consent form may be shared with this third party and the consenting party consents to this sharing of information for educational purposes.

Reporting Guidelines
Data reporting should follow appropriate checklists and guidelines (e.g., STROBE for observational trials; CONSORT for clinical trials), and other checklists should be consulted for other reports including diagnostic accuracy (STARD) or meta-analyses (PRISMA).

Additional guidance on checklists and guidelines can be found here: http://www.equator-network.org/

Checklists can be downloaded from the following:

STROBE: http://strobe-statement.org
CONSORT: http://www.consort-statement.org/consortstatement/
STARD: http://www.stard-statement.org/
PRISMA: http://www.prisma-statement.org/

Redundant and Duplicate Publication
The editors, members of the editorial board, and publisher's staff at MDCP take their responsibility seriously to assure that the highest ethical publishing standards are maintained by assisting in safeguarding the medical scientific literature against fraudulent publications. Please note that all manuscripts are run through plagiarism-detection software as part of the submission process.

Examples of fraud in scientific research include (but are not limited to):

1) The submission of duplicate publications using similar data (i.e., attesting that work submitted is original when, in fact, it was submitted to or accepted by another journal);
2) Falsification of data, copyright, or information regarding conflict of interest;
3) Submission of work from other sources that was not done by the author and is presented as a new and original (plagiarism);
4) Authorship (allowing one’s name to appear as an author or adding an author to a manuscript) without substantial input or without having agreed to submission of the manuscript.

The above examples are not meant to be a comprehensive list of fraudulent publication practices, rather, they should provide adequate basis for careful consideration of avoidable conflicts and editorial scrutiny regarding inappropriate preparation and submission of manuscripts. Manuscripts that have appeared in publications that are not peer-reviewed, are not registered in Pub Med, or are available only on the internet, will be considered for publication in MDCP as long as the Editors are informed and grant approval prior to submission of the manuscript for review. If there are questions as to any issues regarding inappropriate submission, the Editors should be consulted prior to the submission. If a submitted or published manuscript is discovered or suspected to be inappropriate, the authors will be asked for a written explanation. If the rationale provided by the authors remains unsatisfactory in the judgment of the editors, the manuscript will be rejected or retracted. Retractions become a matter of public record and are registered in Pub Med. The provost (or equivalent) of the authors' academic institutions will be informed of inappropriate submissions or publications, and the authors will not be allowed to subsequently submit their research to MDCP. The leadership of MDCP will also inform the editors and publishers of other journals which have published manuscripts judged to be inappropriately submitted to MDCP.

MANUSCRIPT SUBMISSION PROCESS

MDCP is pleased to offer authors a web-based manuscript submission and peer-review process. All manuscripts will be initially evaluated by one of the editors in chief. If the paper does not meet the journal’s standards for peer review, both editors will discuss prior to making an editorial rejection decision. If an editor has a conflict of interest, the other will handle the process without consultation. If peer review is deemed appropriate, the paper will be sent out with the intention of securing one or more reviewers as needed. Reviewers are asked to provide their comments within two weeks, and the editors aim to return decisions on all papers within four weeks of their submission.

Authors may indicate the names of potential referees as well as those whom they wish not to review the paper, but the editor(s) will make the final reviewer decision. Authors will be given a maximum of 60 days for major revisions and 30 days for minor revisions. Authors who plan to resubmit but cannot meet their deadline can contact the editorial office to request an extension; otherwise, the online system will prevent you from uploading the manuscript in the system.

Revisions may receive an immediate decision, may be sent back to the original reviewers, or, in rare cases, sent to new reviewers for additional comments. This decision is at the discretion of the editors in chief.

Getting Started in ScholarOne

  • Authors may submit manuscripts and all supplementary material online at http://mc.manuscriptcentral.com/mdcp.
  • Click on the "Check for Existing Account" button at the bottom of the opening page.
  • If you do not already have an account, then create one by clicking on the "Create an Account" button.
  • Click on “Author Center.” Follow the on-screen instructions carefully.
  • Tables and figures should be uploaded as individual files and not part of the manuscript.
  • At the end of a successful submission, you will see a confirmation screen with your manuscript number, and you will receive a separate e-mail confirming receipt.
  • If these two messages do not appear, then go into your Author Center and make sure that you have clicked on the “Submit” button or contact technical support at: http://mchelp.manuscriptcentral.com/gethelpnow/question.htm.

Cover Letter
The cover letter should briefly describe the scientific or clinical importance of the manuscript. It must confirm that all authors have read the manuscript; the paper has not been previously published, and is not under simultaneous consideration by another journal. Also, a statement that no ghost writing by anyone not named on the author list must be included (see Editorial in Movement Disorders 2005;20:1536. http://onlinelibrary.wiley.com/doi/10.1002/mds.20770/abstract). Identify the corresponding author and provide a complete mailing address, telephone number, and email address for each author, where possible.

Manuscript Formatting
Manuscript pages should be numbered in succession. Please include line-numbering in your manuscript file. The manuscript should be in the following sequence:

(1) Title Page: The opening page of each manuscript must include:

  • Article title: Titles should be short, specific, and clear. They should not exceed 100 characters. Do not use abbreviations/acronyms in the title.
  • Authors' names and affiliations: Indicate the specific affiliation of each author with footnotes (superscripted, Arabic numerals).
  • Name, address, telephone and email address of the corresponding author
  • Word count for main text and Abstract (if applicable)
  • A short running title not exceeding 45 letters and spaces
  • Key words – up to 5

(2) Abstract: Subheadings should only be used if required for the article type. Authors are required to spell out all abbreviations/acronyms in the structured abstract unless this has become accepted in the standard scientific literature (e.g. DNA, MPTP).

(3) Introduction: Give a brief description of the background and relevance of the scientific contribution.

(4) Methods: Describe the methodology of the study. Please include an Ethics Statement if necessary.

(5) Results

(6) Discussion

(7) Acknowledgment: Authors may include as needed, (consistent with requirements of courtesy and disclosure) participation of contributors to the study who are not included in the author list. Do not include funding information in this section.

(8) Author Roles: At the end of the manuscript, all authors must be listed, along with their specific roles in the project and manuscript preparation. These should include but not be restricted to:
1. Research project: A. Conception, B. Organization, C. Execution;
2. Statistical Analysis: A. Design, B. Execution, C. Review and Critique;
3. Manuscript Preparation: A. Writing of the first draft, B. Review and Critique;

(9) Disclosures: All submissions require a “Disclosures” section that covers the financial disclosures and conflicts of interest for all authors. This should be presented in complete sentences and organized under the headings below:

Funding Sources and Conflict of Interest: document all funding sources and potential conflicts of interest from each author that relate to the research covered in the article, regardless of date.

If none, please state: “No specific funding was received for this work” and/or “The authors declare that there are no conflicts of interest relevant to this work.”

Financial Disclosures for the previous 12 months: document all funding sources, not related to the current research in the article, from each author.

If none, please state: “The authors declare that there are no additional disclosures to report.”

The copyright form that is signed by each author confirms that both of these entries are documented in the submitted material.

(10) Compliance with Journal Ethical Publication Guidelines Statement
Authors are required to include a statement at the end of their manuscript affirming that they have read the Journal’s Ethical Publication Guidelines (see above): “We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.”

(11) References: Movement Disorders Clinical Practice complies with the reference style given in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals." (See Annals of Internal Medicine 1982;96:766-771, or British Medical Journal 1982:284:1766-1770.) References are to be cited sequentially in the text by number, and in the list of References they are to be numbered in the order in which they are cited. The reference section should be double-spaced at the end of the text, following the sample formats given below. Provide all authors' names when fewer than seven; when seven or more, list the first three and add ‘et al’. Provide article titles and inclusive pages. Accuracy of reference data is the responsibility of the author. For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus (available from the Superintendent of Documents, U.S. Government Printing Office, Washington DC 20402, USA, DHEW Publication No. (NIH) 83-267; ISSN 0093-3821).

Sample References
Journal article

1. Krack P, Benzzzouz A, Pollak P, et al. Treatment of tremor in Parkinson’s disease by Subthalamic nucleus stimulation. Mov Disord 1998; 13: 907-914.

Book

2. Fahn S, Jankovic J, editors. Principles and Practice of Movement Disorders, Philadelphia, Churchill Livingstone, 2010, pp 96.

Chapter in a book

3. Olanow CW. Hyperkinetic Movement Disorders. In: Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson JL, Loscalzo J. Eds. Harrison’s Textbook of Medicine 17th edition. 2008; p2560-2565.

(12) Legends for Figure(s) and Supplemental file(s): See the Video Submission section above for specific video legend requirements. Tables and Figure legends should be double-spaced and fewer than 40 words. For photomicrographs, please include the type of specimen, original magnification, and stain type. Include internal scale-markers on photomicrographs when appropriate. Where applicable, indicate the method used to digitally enhance images. Every supplemental file should have a corresponding legend in the manuscript file.

Tables
Tables should be typed neatly, each on a separate page, with a title above and any notes below. Define all abbreviations. Do not repeat the same information in tables and figures that is present in text. Tables should be uploaded as individual files and not part of the manuscript text. Please use portrait orientation (vertical) instead of landscape (horizontal). Font size should be at least 9pt and single-page tables are preferred. Tables that are especially wide and/or heavy in text may have to be rotated during typesetting.

Figures and Illustrations
Figures should be uploaded as individual files and not part of the manuscript text. Any illustration or figure from another publication must be acknowledged in the figure legend and the copyright holder’s written permission to (re)use any image online in MDCP must be submitted to the editorial office.

Digital Artwork Preparation
1. Check your software options to see if you can ‘save as’ or ‘export’ using one of the robust, industry-standard formats. These are:

  • Encapsulated PostScript (EPS)
  • Tagged Image File Format (TIFF)
  • Portable Network Graphics (PNG)
  • Portable Document Format (PDF)

2. As a general rule of thumb, images that contain text and line art (graphs, charts, maps, etc.) will reproduce best if saved as EPS or PDF. If you choose this option, it is important to remember to embed fonts. This ensures that any text reproduces exactly as you intend.

3. Images that contain photographic information are best saved as TIFF or PNG, as this ensures that all data are included in the file. JPEG (Joint Photographic Experts Group) should be avoided if possible, as information is lost during compression; however, it is acceptable for purely photographic subjects if the image was generated as a JPEG from the outset (many digital cameras, for example, output only in JPEG format).

4. If you are not sure which format would be the best option, it is always best to default to EPS or PDF as these are more likely to preserve the high-quality characteristics of the original.

5. Microsoft Office. If you have generated your images in Microsoft Office software (Word, Excel, PowerPoint), or similar, it is often best simply to send us the files in their native file formats.

6. Please ensure all images are a minimum of 600 dpi

Video Submission

File size limitations and length:

  • Files may be no larger than two and half minutes each unless formal approval is obtained from the editorial office.
  • Please limit file size to 50MB, if possible.
  • For optimal viewing, please make your videos 480x360 pixels.
  • Videos must include an audio soundtrack to work on the corresponding International Parkinson and Movement Disorders site.

Legends:

  • Authors must supply a video legend at the end of the article, labeled “Video 1, Video 2,” etc. and should concisely and sequentially describe what is seen in the video so that it can be readily understood. Do not repeat explanatory material that is already in text.
  • If there are multiple segments in a video, please identify what happens in each segment (Segment 1, Segment 2, etc.)
  • The video should be labelled and should directly follow the sequence and content of the video legend.

General Information:

  • If an article includes a video, the upper right corner of the title page of the manuscript file must be marked “Video is part of ms.”
  • Video must be submitted with manuscripts online in one of the following digital formats: asf, avi, flv, mov, mp3, mp4, mpeg, mpg, wav, wma, wmv.
  • Videos must include an audio soundtrack to work on the corresponding International Parkinson and Movement Disorders site.

Content:

  • Video content should be edited to illustrate the key findings in a concise and informative manner. The video should be of high quality (both in content and visibility). The video should be edited to ensure maximal efficiency and make the specific point; particularly, it should demonstrate the features described in the text of the manuscript.
  • The use of text and/or special transition effects between the titles, subtitles and video segments is permitted. The video you submit should be the final product that will be published with the article.
  • The Editors reserve the right to request additional video editing by the authors (which may delay publication).

Patient Consent:

  • The corresponding author must confirm in the author copyright form (Article V) that he or she has received a signed release form from each patient videotaped authorizing the offline and/or online distribution of this video material. Manuscripts with videos will not be accepted until the signed copyright form (Article V) with appropriate documentation is received.

ARTICLE TYPES AND LENGTH REQUIREMENTS

Given below are the types of articles and the word count guidelines for all MDCP submissions. The word count excludes the title page, abstract, tables, acknowledgements and contributions, and references.

Article Type

Description

Word count

Abstract

Refs

Tables / Figures

Clinical Research Articles

Clinical Research Articles must present important and substantial new material. Articles can be clinical material, electrophysiology, genetics, clinico-pathological or therapeutics with a direct relevance to clinical practice.

3,000

250 words,
structured subheadings

80

8 max

Drug Trials

Drug Trials (including negative drug trials) will be considered as well.

3,000

250 words,
structured subheadings

80

8 max

Case Reports

Topics suitable for presentation for short reports include a single case which illustrates new phenomena, or original clinical research.

800

N/A

10

2 max

Case Series

Topics suitable for presentation for short reports include case series which illustrate new phenomena, or original clinical research.

1,500

150 words,
structured subheadings

10

2 max

Reviews

Unsolicited Reviews may be submitted, and prior editorial approval is not required. Evidence-Based Reviews are included in this section. We encourage authors to include, in boxes, bulleted points of the main messages of the review.

5,000

250 words,
structured subheadings

80

5 max

Editorials and Viewpoints

Editorials will generally be solicited by the editors and are subjected to a review process. Authors wishing to submit an editorial should seek the advice of the editors in advance. Viewpoints related to any aspect of movement disorders may be submitted without solicitation.

1,500

N/A

25

1 max

Clinical Vignettes

These are interesting cases that are not necessarily original but highlight differential diagnosis, imaging or a treatment aspect (i.e. postural tremor in a patient with absent reflexes). There should be no more than four authors. Clinical Vignettes that are mainly based in a video segment may have a Commentary by an expert in the area. Additional material, e.g. video clips and sound files, is recommended.

500

N/A

5

N/A

Phenomenology Video

These submissions include videos illustrating phenomenology of movement disorders (i.e. different forms of myoclonus) with an educational multiple choice question. Correct answers for the multiple choice question and explanation to be provided (with references). Format the text using the subheadings: Case Description, Question, and Answer. This may be solicited by the editors or non-solicited.

300*

N/A

2

N/A

Revealing Images

Revealing Images are interesting, previously unpublished photomicrographs, patient photographs, neuroradiologic images, or other pictorial material. For example, novel or unique imaging including MRI, DAT Scans, DTI or other, and also EMG video recording or video of microrecordings from functional surgery. These should be accompanied by a paragraph of explanation. Authors may choose to include one multiple choice question along with a list of possible answers, including an indication and explanation of the correct answer.

200^

N/A

2

2

Clinico-Pathological Cases

These are cases with pathological diagnosis. The article should have an illustrative clinical report and post-mortem or other diagnostic pathology with good illustration. Authors will prepare the case including the pathological findings. Editors will select a discussant to provide educative commentary.

2,000~

250 words,
structured subheadings

15

3 max

Historical Notes

Interesting old tapes/videos, sound recordings, photographs or seminal historical papers, or previously published commentary by the author.

500

N/A

5

3 max

Letters

Letters in response to articles published in MDCP are welcome. Letters containing original research which is not covered by any of the topics mentioned above will also be considered.

500

N/A

5

1 max

BY INVITATION ONLY

In Focus

In Focus submissions are reports of breakthrough findings published elsewhere which deserve a comment in the journal. Please send a proposal to the MDCP Editorial Office prior to submitting.

500

N/A

5

1 table

How Do I?

The editors will solicit educational video illustrated algorithm about a particular movement disorder topic regarding a clinical approach or investigations/ diagnosis/treatment (for example: How do I examine a patient with a tremor disorder?). This is a multimedia video-based article. Detailed instructions will be sent to all invited authors via e-mail.

800

250 words, structured subheadings

5

N/A

*The Phenomenology Video includes educational multiple choice question and answer
^The text for Revealing Images will be a self-explanatory legend for the image(s)
~For Clinico-Pathological Cases, word count includes 1,500 for the case and 500 for the discussion

Author Copyright Form and Legal Information
The author Copyright form includes (1) a statement on authorship responsibility, (2) a statement on financial disclosure (Exhibit A), questions regarding copyright and federal employment, and instructions regarding a statement of acknowledgment (Clause I). The full agreement must be read and hand-signed by each co-author. Electronic signatures cannot be accepted. The corresponding author must sign the acknowledgment statement (5) if the contribution includes, discloses, or incorporates any content (including any video or photograph) which identifies any individual patient(s), the Contributor must obtain written consent per Clause V of the Copyright Transfer Agreement.

Group Authorship. The journal does not limit the number of authors for an individual manuscript (unless otherwise specified) providing that: a) If there are multiple authors, all authors must meet the full criteria and requirements for authorship; b) If there is group authorship, one or more individuals are designated as authors or members of a writing group who meet full authorship criteria and who take responsibility for the group. Other members of the group are not authors individually, may be listed in the acknowledgment section (Flanagin A, Fontanarosa PB, DeAngelis CD. Authorship for research groups. JAMA 2002;288:3166-3168).

Data Access and Responsibility. For clinical trials sponsored by pharmaceutical companies, authors must state in their letter of submission that (1) they have had full access to the data, (2) they have the right to publish all the data, and (3) they have had the right to obtain independent statistical analyses of the data. For any report containing original data, at least one author should indicate that he or she “takes responsibility for the integrity of the data and the accuracy of the data analysis” (DeAngelis CD, Fontanarosa PB, Flanagan A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001;286:89-91).

Copyright. The International Parkinson and Movement Disorder Society will hold copyright to all published articles and videos. The copyright transfer agreement form is available here and can also be downloaded at the Scholar One site. If you are a government employee, please check the “Government-Owned Work” checkbox.

English Language Editing Services
Authors who are not perfectly fluent in English should have their manuscript professionally edited before submission. A list of independent suppliers of editing services can be found at: http://wileyeditingservices.com/en/ All services must be arranged and paid for by the author, and use of one of these services does not guarantee acceptance for publication. The journal will copyedit accepted papers to ensure uniformity of language and style. American spelling, rather than British, is preferred.

Accepted Articles
The journal has an Accepted Articles section, in which articles will appear online at the time of acceptance. This temporary posting will occur before copyediting, typesetting, and proofreading to allow MDCP papers to be accessible and cited sooner in the publication process. At the time of final publication, the accepted version will be replaced by the copyedited, typeset, and proofread version. Supplementary materials will NOT be included in the E-pub ahead of print version of articles.

Expedited Publications (Fast Track): MDCP will attempt to accommodate authors of manuscripts dealing with extremely topical issues or with findings of great scientific or clinical importance by offering Expedited Review and Publication. Expedited papers will be rapidly reviewed and published in the next issue.

OnlineOpen/Open Access
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. The current fee for this service is $3000. For the full list of terms and conditions, see: http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms

Any authors wishing to send their paper to OnlineOpen will be required to complete the payment form available from our website at: https://onlinelibrary.wiley.com/onlineOpenOrder.

Prior to acceptance, there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

Supplements
MDCP is willing to consider publishing supplements to regular issues. Supplement proposals may be made at the request of or by:

  • The journal editors, an editorial board member or a learned MDS society member who may wish to organize a meeting. Sponsorship may be sought and the proceedings published as a supplement.
  • The journal editor, editorial board member or learned society member may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought.
  • A sponsoring organization, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement.

In all cases, it is vital that the journal's integrity, independence and academic reputation are not compromised in any way. When contacting the editors regarding a potential supplement, please include as much of the information below as possible.

  • Title of supplement and/or meeting on which it is based
  • Date of meeting on which it is based
  • Proposed table of contents with provisional article titles and proposed authors
  • An indication of whether authors have agreed to participate
  • Sponsorship information, including any relevant deadlines
  • An indication of the expected length of each paper and guest editor proposals, if appropriate

Please note that acceptance of a supplement proposal does not guarantee publication. Supplements will only be published upon passing peer and editorial review.

SEARCH

SEARCH BY CITATION